Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31true22023-04-01falseNo description of principal activity3trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 08359790 2023-04-01 2024-03-31 08359790 2022-04-01 2023-03-31 08359790 2024-03-31 08359790 2023-03-31 08359790 c:Director2 2023-04-01 2024-03-31 08359790 d:PlantMachinery 2023-04-01 2024-03-31 08359790 d:PlantMachinery 2024-03-31 08359790 d:PlantMachinery 2023-03-31 08359790 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08359790 d:MotorVehicles 2023-04-01 2024-03-31 08359790 d:MotorVehicles 2024-03-31 08359790 d:MotorVehicles 2023-03-31 08359790 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08359790 d:FurnitureFittings 2023-04-01 2024-03-31 08359790 d:FurnitureFittings 2024-03-31 08359790 d:FurnitureFittings 2023-03-31 08359790 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08359790 d:OfficeEquipment 2023-04-01 2024-03-31 08359790 d:OfficeEquipment 2024-03-31 08359790 d:OfficeEquipment 2023-03-31 08359790 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08359790 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 08359790 d:CurrentFinancialInstruments 2024-03-31 08359790 d:CurrentFinancialInstruments 2023-03-31 08359790 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 08359790 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 08359790 d:ShareCapital 2024-03-31 08359790 d:ShareCapital 2023-03-31 08359790 d:RetainedEarningsAccumulatedLosses 2024-03-31 08359790 d:RetainedEarningsAccumulatedLosses 2023-03-31 08359790 c:FRS102 2023-04-01 2024-03-31 08359790 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 08359790 c:FullAccounts 2023-04-01 2024-03-31 08359790 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08359790 2 2023-04-01 2024-03-31 08359790 d:AcceleratedTaxDepreciationDeferredTax 2024-03-31 08359790 d:AcceleratedTaxDepreciationDeferredTax 2023-03-31 08359790 d:OtherDeferredTax 2024-03-31 08359790 d:OtherDeferredTax 2023-03-31 08359790 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 08359790










CHAMELEON CONSULTING (HEALTHCARE) LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
REGISTERED NUMBER: 08359790

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
61,429
79,981

  
61,429
79,981

Current assets
  

Debtors: amounts falling due within one year
 5 
140,736
78,206

Cash at bank and in hand
 6 
179,982
107,718

  
320,718
185,924

Creditors: amounts falling due within one year
 7 
(80,942)
(28,179)

Net current assets
  
 
 
239,776
 
 
157,745

Total assets less current liabilities
  
301,205
237,726

Provisions for liabilities
  

Deferred tax
 8 
(15,357)
(19,995)

  
 
 
(15,357)
 
 
(19,995)

Net assets
  
285,848
217,731


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
285,748
217,631

  
285,848
217,731


Page 1

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
REGISTERED NUMBER: 08359790
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




R Maiden
Director

Date: 21 November 2024

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The company, which was incorporated and registered in England & Wales (registered number 8359790), is a privately owned company limited by shares. The registered office address is Wey Court West, Union Road, Farnham, Surrey, GU9 7PT.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)


2.3
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, as follows:.

Depreciation is provided on the following basis:

Plant and machinery
-
10% Straight line
Motor vehicles
-
20% Straight line
Fixtures and fittings
-
25% Reducing balance
Office equipment
-
33.3 % Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.7

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.8

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the company in independently administered funds.

 
2.9

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.10

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.11

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Page 5

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2023 - 2).


4.


Tangible fixed assets





Plant and machinery
Motor vehicles
Fixtures and fittings
Office equipment
Total

£
£
£
£
£



Cost or valuation


At 1 April 2023
19,287
94,710
5,955
26,510
146,462


Additions
-
-
-
2,401
2,401



At 31 March 2024

19,287
94,710
5,955
28,911
148,863



Depreciation


At 1 April 2023
19,275
18,942
5,043
23,221
66,481


Charge for the year on owned assets
12
18,942
228
1,771
20,953



At 31 March 2024

19,287
37,884
5,271
24,992
87,434



Net book value



At 31 March 2024
-
56,826
684
3,919
61,429



At 31 March 2023
12
75,768
912
3,289
79,981


5.


Debtors

2024
2023
£
£


Trade debtors
8,480
57,377

Other debtors
130,887
20,191

Prepayments and accrued income
1,369
638

140,736
78,206


Page 6

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
179,982
107,718

179,982
107,718



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
54,756
17,750

Other taxation and social security
1,664
-

Other creditors
22,272
8,419

Accruals and deferred income
2,250
2,010

80,942
28,179



8.


Deferred taxation




2024


£






At beginning of year
(19,995)


Charged to the profit or loss
4,638



At end of year
(15,357)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(15,357)
(24,881)

Charged to the profit or loss
-
4,886

(15,357)
(19,995)

Page 7

 
CHAMELEON CONSULTING (HEALTHCARE) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

9.


Pension commitments

The company operates a difined contribution pension scheme.  The assets of the scheme are held separately from those of the company in an independently administered fund.  The pension cost charge represents contributions payable by the company to the fund and amounted to £70,000 (2023: £30,000).  There were no pension liabilities at the year end. 

 
Page 8